As a well-characterized proinflammatory cytokine, IL-1β is associated with more aggressive phenotype and higher tumor grade in breast cancer [35], and genetic variations of IL-1β and IL-1R1 may predict breast cancer risk and prognosis [36, 37]. This evidence concerns the gene IL1B and neoplasm.